XML 175 R152.htm IDEA: XBRL DOCUMENT
v3.23.1

List of principal subsidiaries - Disclosure of the principal subsidiaries of the Company (Details) | 12 Months Ended |
--- | --- | ---
Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2022 HKD ($) | Dec. 31, 2022 GBP (£) | Dec. 31, 2022 TWD ($)
Disclosure of subsidiaries [line items] |  |  |  |  |
Issued capital | $ 13,698 | $ 1,493 |  |  |
Prenetics Limited [member] |  |  |  |  |
Disclosure of subsidiaries [line items] |  |  |  |  |
Name of subsidiaries | Prenetics Limited |  |  |  |
Place of incorporation/ operation | Hong Kong |  |  |  |
Issued capital |  |  | $ 415,276,716 |  |
Proportion of ownership interest in subsidiary | 0.00% | 0.00% |  |  |
Proportion of voting rights held in subsidiary | 100.00% | 100.00% |  |  |
Description of nature of entity's operations and principal activities | Genetic and diagnostic health testing |  |  |  |
Prenetics EMEA Limited [member] |  |  |  |  |
Disclosure of subsidiaries [line items] |  |  |  |  |
Name of subsidiaries | Prenetics EMEA Limited |  |  |  |
Place of incorporation/ operation | United Kingdom |  |  |  |
Issued capital | £ |  |  |  | £ 76,765.81 |
Proportion of ownership interest in subsidiary | 0.00% | 0.00% |  |  |
Proportion of voting rights held in subsidiary | 100.00% | 100.00% |  |  |
Description of nature of entity's operations and principal activities | Genetic and diagnostic health testing |  |  |  |
ACT Genomics Holdings Company Limited [member] |  |  |  |  |
Disclosure of subsidiaries [line items] |  |  |  |  |
Name of subsidiaries | ACT Genomics Holdings Company Limited (note 33) |  |  |  |
Place of incorporation/ operation | Cayman Islands |  |  |  |
Issued capital | $ 16,713 |  |  |  |
Proportion of ownership interest in subsidiary | 74.39% | 0.00% |  |  |
Proportion of voting rights held in subsidiary | 0.00% | 0.00% |  |  |
Description of nature of entity's operations and principal activities | Precise cancer genetic testing services |  |  |  |
ACT Genomics Co., Ltd. [Member] |  |  |  |  |
Disclosure of subsidiaries [line items] |  |  |  |  |
Name of subsidiaries | ACT Genomics Co., Ltd. |  |  |  |
Place of incorporation/ operation | Taiwan |  |  |  |
Issued capital |  |  |  |  | $ 455,080,000
Proportion of ownership interest in subsidiary | 0.00% | 0.00% |  |  |
Proportion of voting rights held in subsidiary | 74.33% | 0.00% |  |  |
Description of nature of entity's operations and principal activities | Precise cancer genetic testing - services |  |  |  |
ACT Genomics Hong Kong Limited [Member] |  |  |  |  |
Disclosure of subsidiaries [line items] |  |  |  |  |
Name of subsidiaries | ACT Genomics (Hong Kong) Limited |  |  |  |
Place of incorporation/ operation | Hong Kong |  |  |  |
Issued capital |  |  | 775,000 |  |
Proportion of ownership interest in subsidiary | 0.00% | 0.00% |  |  |
Proportion of voting rights held in subsidiary | 74.39% | 0.00% |  |  |
Description of nature of entity's operations and principal activities | Precise cancer genetic testing - services |  |  |  |
Sanomics Limited [Member] |  |  |  |  |
Disclosure of subsidiaries [line items] |  |  |  |  |
Name of subsidiaries | Sanomics Limited |  |  |  |
Place of incorporation/ operation | Hong Kong |  |  |  |
Issued capital |  |  | $ 500,000 |  |
Proportion of ownership interest in subsidiary | 0.00% | 0.00% |  |  |
Proportion of voting rights held in subsidiary | 74.39% | 0.00% |  |  |
Description of nature of entity's operations and principal activities | Precise cancer genetic testing - services |  |  |  |
MC Diagnostics Limited [Member] |  |  |  |  |
Disclosure of subsidiaries [line items] |  |  |  |  |
Name of subsidiaries | MC Diagnostics Limited |  |  |  |
Place of incorporation/ operation | United Kingdom |  |  |  |
Issued capital | £ |  |  |  | £ 1,164 |
Proportion of ownership interest in subsidiary | 0.00% | 0.00% |  |  |
Proportion of voting rights held in subsidiary | 74.39% | 0.00% |  |  |
Description of nature of entity's operations and principal activities | Sales of medical diagnostics products |  |  |  |

X
- Definition The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 16 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_ii&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 17 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_ii&doctype=Standard -URIDate 2022-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2022-03-24 -Paragraph 12 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_b&doctype=Standard -URIDate 2022-03-24 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2022-03-24 -Paragraph 19B -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_b&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the nature of the entity's operations and principal activities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 138 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_138_b&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The nominal value of capital issued. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 78 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_IssuedCapital
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The name of a subsidiary. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 17 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_i&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 16 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_i&doctype=Standard -URIDate 2022-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2022-03-24 -Paragraph 12 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_a&doctype=Standard -URIDate 2022-03-24 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2022-03-24 -Paragraph 19B -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_NameOfSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 17 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 16 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2022-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2022-03-24 -Paragraph 19B -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_c&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestInSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of the voting rights in a subsidiary held by the entity. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 17 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 16 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2022-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2022-03-24 -Paragraph 19B -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_c&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_ProportionOfVotingPowerHeldInSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_PreneticsLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_PreneticsEmeaLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_ActGenomicsHoldingsCompanyLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_ActGenomicsCo.Ltd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_ActGenomicsHongKongLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_SanomicsLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_McDiagnosticsLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |